Nomura, Kyoichi

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet

Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling

Cited by 942

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies

Kaneko, K., Sato, D. K., Nakashima, I., Nishiyama, S., Tanaka, S., Marignier, R., Hyun, J.-W., Oliveira, L. M. D., Reindl, M., Seifert-Held, T., et al. (2016) · Journal of Neurology, Neurosurgery & Psychiatry

Multiple Sclerosis Research StudiesAutoimmune Neurological Disorders and Treatments

Cited by 106